Literature DB >> 22871911

Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression co-morbidity.

S Alisha Epps1, Kroshona D Tabb, Sharon J Lin, Alexa B Kahn, Martin A Javors, Katherine A Boss-Williams, Jay M Weiss, David Weinshenker.   

Abstract

Although a strong co-morbidity exists clinically between epilepsy and depression, the cause of this co-morbidity remains unknown, and a valid animal model is crucial for the identification of underlying mechanisms and the development of a screening tool for novel therapies. Although some rodent models of epilepsy have been reported to display behaviors relevant to affective disorders, the seizure susceptibility of animals prone to depression-like behavior has not been characterized. Toward this end, we assessed several forms of seizure sensitivity and epileptogenesis in rats selectively bred for vulnerability (Swim Lo-Active; SwLo) or resilience (Swim High-Active; SwHi) to depression-like phenotypes. The SwLo rats exhibit decreased motor activity in a swim test and other depression-like phenotypes, whereas the SwHi rats display increased motor activity in a swim test. SwLo rats exhibited a decreased latency to limbic motor seizures following acute pilocarpine administration in the absence of differences in pilocarpine pharmacokinetics, and also had a decreased threshold to tonic seizures induced by electroshock. Approximately half of the SwLo rats, but none of the SwHi rats, had spontaneous limbic motor seizures 5 weeks following pilocarpine-induced status epilepticus. While the number of stimulations required to achieve full amygdala and hippocampal electrical kindling were similar in the two rat lines, SwLo rats had a lower final hippocampal kindling threshold and more wet dog shakes during both amygdala and hippocampal kindling. Combined, these results indicate that SwLo rats are a model of epilepsy and depression co-morbidity that can be used for investigating underlying neurobiological and genetic mechanisms and screening novel therapeutics.

Entities:  

Mesh:

Year:  2012        PMID: 22871911      PMCID: PMC3499730          DOI: 10.1038/npp.2012.141

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  53 in total

1.  Depression and anxiety in epilepsy patients.

Authors:  Cynthia L. Harden
Journal:  Epilepsy Behav       Date:  2002-06       Impact factor: 2.937

Review 2.  Antidepressant overdose-induced seizures.

Authors:  Bryan S Judge; Landen L Rentmeester
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

3.  Increased afterdischarge threshold during kindling in epileptic rats.

Authors:  Anatol Bragin; Charles L Wilson; Jerome Engel
Journal:  Exp Brain Res       Date:  2002-03-02       Impact factor: 1.972

4.  Depression and Anxiety in Patients with Epilepsy.

Authors:  Ada Piazzini; Maria Paola Canevini; Giovanna Maggiori; Raffaele Canger
Journal:  Epilepsy Behav       Date:  2001-10       Impact factor: 2.937

5.  Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression.

Authors:  J M Weiss; M A Cierpial; C H West
Journal:  Pharmacol Biochem Behav       Date:  1998-09       Impact factor: 3.533

6.  Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice.

Authors:  Y Kitano; C Usui; K Takasuna; M Hirohashi; M Nomura
Journal:  J Pharmacol Toxicol Methods       Date:  1996-02       Impact factor: 1.950

7.  Self-perception of seizure precipitants and their relation to anxiety level, depression, and health locus of control in epilepsy.

Authors:  Michael R Sperling; Courtney A Schilling; David Glosser; Joseph I Tracy; Ali A Asadi-Pooya
Journal:  Seizure       Date:  2007-10-31       Impact factor: 3.184

8.  Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation.

Authors:  Nigel C Jones; Michael R Salzberg; Gaurav Kumar; Abbie Couper; Margaret J Morris; Terence J O'Brien
Journal:  Exp Neurol       Date:  2007-10-05       Impact factor: 5.330

Review 9.  The role of norepinephrine in epilepsy: from the bench to the bedside.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Francesca Biagioni; Luigi Murri; Francesco Fornai
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

10.  Stress and epilepsy: a patient perception survey.

Authors:  Sheryl R Haut; Mary Vouyiouklis; Shlomo Shinnar
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

View more
  12 in total

Review 1.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

2.  Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice.

Authors:  Prashant Koshal; Puneet Kumar
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

3.  Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice.

Authors:  Prashant Koshal; Puneet Kumar
Journal:  Mol Cell Biochem       Date:  2016-03-10       Impact factor: 3.396

4.  Antidepressant and anticonvulsant effects of exercise in a rat model of epilepsy and depression comorbidity.

Authors:  S Alisha Epps; Alexa B Kahn; Philip V Holmes; Katherine A Boss-Williams; Jay M Weiss; David Weinshenker
Journal:  Epilepsy Behav       Date:  2013-08-08       Impact factor: 2.937

Review 5.  Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 6.  Rhythm and blues: animal models of epilepsy and depression comorbidity.

Authors:  S Alisha Epps; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

Review 7.  Serotonergic therapy in epilepsy.

Authors:  Frank G Gilliam; Hrvoje Hecimovic; Matthew S Gentry
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 5.710

Review 8.  Depression and Anxiety in the Epilepsies: from Bench to Bedside.

Authors:  Vaishnav Krishnan
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 6.030

9.  A reliable method for intracranial electrode implantation and chronic electrical stimulation in the mouse brain.

Authors:  Melanie Jeffrey; Min Lang; Jonathan Gane; Chiping Wu; W McIntyre Burnham; Liang Zhang
Journal:  BMC Neurosci       Date:  2013-08-06       Impact factor: 3.288

10.  Olfactory Bulbectomy Leads to the Development of Epilepsy in Mice.

Authors:  Yifei Jiang; Raymund Y K Pun; Katrina Peariso; Katherine D Holland; Qingquan Lian; Steve C Danzer
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.